Form 8-K - Current report:
SEC Accession No. 0001641172-25-003881
Filing Date
2025-04-11
Accepted
2025-04-11 17:00:36
Documents
14
Period of Report
2025-04-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35120
  Complete submission text file 0001641172-25-003881.txt   210883

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mgrx-20250410.xsd EX-101.SCH 3032
3 XBRL LABEL FILE mgrx-20250410_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE mgrx-20250410_pre.xml EX-101.PRE 22370
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3800
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 25832887
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)